全文获取类型
收费全文 | 2005篇 |
免费 | 54篇 |
国内免费 | 12篇 |
专业分类
管理学 | 103篇 |
民族学 | 5篇 |
人口学 | 129篇 |
丛书文集 | 31篇 |
理论方法论 | 21篇 |
综合类 | 519篇 |
社会学 | 24篇 |
统计学 | 1239篇 |
出版年
2024年 | 1篇 |
2023年 | 9篇 |
2022年 | 10篇 |
2021年 | 23篇 |
2020年 | 33篇 |
2019年 | 38篇 |
2018年 | 62篇 |
2017年 | 86篇 |
2016年 | 57篇 |
2015年 | 53篇 |
2014年 | 71篇 |
2013年 | 544篇 |
2012年 | 165篇 |
2011年 | 85篇 |
2010年 | 69篇 |
2009年 | 77篇 |
2008年 | 95篇 |
2007年 | 75篇 |
2006年 | 72篇 |
2005年 | 63篇 |
2004年 | 54篇 |
2003年 | 52篇 |
2002年 | 35篇 |
2001年 | 38篇 |
2000年 | 38篇 |
1999年 | 20篇 |
1998年 | 24篇 |
1997年 | 16篇 |
1996年 | 10篇 |
1995年 | 13篇 |
1994年 | 14篇 |
1993年 | 5篇 |
1992年 | 8篇 |
1991年 | 9篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 6篇 |
1987年 | 2篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 4篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有2071条查询结果,搜索用时 15 毫秒
41.
Ridhi Kashyap 《Population studies》2019,73(1):57-78
I examine whether prenatal sex selection has substituted postnatal excess female mortality by analysing the dynamics of child sex ratios between 1980 and 2015 using country-level life table data. I decompose changes in child sex ratios into a ‘fertility’ component attributable to prenatal sex selection and a ‘mortality’ component attributable to sex differentials in postnatal survival. Although reductions in numbers of excess female deaths have accompanied increases in missing female births in all countries experiencing the emergence of prenatal sex selection, relative excess female mortality has persisted in some countries but not others. In South Korea, Armenia, and Azerbaijan, mortality reductions favouring girls accompanied increases in prenatal sex selection. In India, excess female mortality was much higher and largely stable as prenatal sex selection emerged, but slight reductions were seen in the 2000s. In China, although absolute measures showed reductions, relative excess female mortality persisted as prenatal sex selection increased. 相似文献
42.
In recent years, seamless phase I/II clinical trials have drawn much attention, as they consider both toxicity and efficacy endpoints in finding an optimal dose (OD). Engaging an appropriate number of patients in a trial is a challenging task. This paper attempts a dynamic stopping rule to save resources in phase I/II trials. That is, the stopping rule aims to save patients from unnecessary toxic or subtherapeutic doses. We allow a trial to stop early when widths of the confidence intervals for the dose-response parameters become narrower or when the sample size is equal to a predefined size, whichever comes first. The simulation study of dose-response scenarios in various settings demonstrates that the proposed stopping rule can engage an appropriate number of patients. Therefore, we suggest its use in clinical trials. 相似文献
43.
Applying the large and moderate deviations for the log-likelihood ratio of the Rayleigh diffusion model, we give the negative regions in testing Rayleigh diffusion model and obtain the decay rates of the error probabilities. 相似文献
44.
Logarithmic general error distribution, an extension of the log-normal distribution, is proposed. Some interesting properties of the log GED are derived. These properties are applied to establish the asymptotic behavior of the ratio of probability densities and the ratio of the tails of the logarithmic general error and log-normal distributions, and to derive the asymptotic distribution of the partial maximum of an independent and identically distributed sequence obeying the log GED. 相似文献
45.
In this paper, we propose a multiple deferred state repetitive group sampling plan which is a new sampling plan developed by incorporating the features of both multiple deferred state sampling plan and repetitive group sampling plan, for assuring Weibull or gamma distributed mean life of the products. The quality of the product is represented by the ratio of true mean life and specified mean life of the products. Two points on the operating characteristic curve approach is used to determine the optimal parameters of the proposed plan. The plan parameters are determined by formulating an optimization problem for various combinations of producer's risk and consumer's risk for both distributions. The sensitivity analysis of the proposed plan is discussed. The implementation of the proposed plan is explained using real-life data and simulated data. The proposed plan under Weibull distribution is compared with the existing sampling plans. The average sample number (ASN) of the proposed plan and failure probability of the product are obtained under Weibull, gamma and Birnbaum–Saunders distributions for a specified value of shape parameter and compared with each other. In addition, a comparative study is made between the ASN of the proposed plan under Weibull and gamma distributions. 相似文献
46.
Measures of statistical divergence are used to assess mutual similarities between distributions of multiple variables through a variety of methodologies including Shannon entropy and Csiszar divergence. Modified measures of statistical divergence are introduced throughout the present article. Those modified measures are related to the Lin–Wong (LW) divergence applied on the past lifetime data. Accordingly, the relationship between Fisher information and the LW divergence measure was explored when applied on the past lifetime data. Throughout this study, a number of relations are proposed between various assessment methods which implement the Jensen–Shannon, Jeffreys, and Hellinger divergence measures. Also, relations between the LW measure and the Kullback–Leibler (KL) measures for past lifetime data were examined. Furthermore, the present study discusses the relationship between the proposed ordering scheme and the distance interval between LW and KL measures under certain conditions. 相似文献
47.
Development of predictive signatures for treatment selection in precision medicine with survival outcomes
下载免费PDF全文
![点击此处可从《Pharmaceutical statistics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
For survival endpoints in subgroup selection, a score conversion model is often used to convert the set of biomarkers for each patient into a univariate score and using the median of the univariate scores to divide the patients into biomarker‐positive and biomarker‐negative subgroups. However, this may lead to bias in patient subgroup identification regarding the 2 issues: (1) treatment is equally effective for all patients and/or there is no subgroup difference; (2) the median value of the univariate scores as a cutoff may be inappropriate if the sizes of the 2 subgroups are differ substantially. We utilize a univariate composite score method to convert the set of patient's candidate biomarkers to a univariate response score. We propose applying the likelihood ratio test (LRT) to assess homogeneity of the sampled patients to address the first issue. In the context of identification of the subgroup of responders in adaptive design to demonstrate improvement of treatment efficacy (adaptive power), we suggest that subgroup selection is carried out if the LRT is significant. For the second issue, we utilize a likelihood‐based change‐point algorithm to find an optimal cutoff. Our simulation study shows that type I error generally is controlled, while the overall adaptive power to detect treatment effects sacrifices approximately 4.5% for the simulation designs considered by performing the LRT; furthermore, the change‐point algorithm outperforms the median cutoff considerably when the subgroup sizes differ substantially. 相似文献
48.
Survival bias is a long recognized problem in case–control studies, and many varieties of bias can come under this umbrella term. We focus on one of them, termed Neyman's bias or ‘prevalence–incidence bias’. It occurs in case–control studies when exposure affects both disease and disease-induced mortality, and we give a formula for the observed, biased odds ratio under such conditions. We compare our result with previous investigations into this phenomenon and consider models under which this bias may or may not be important. Finally, we propose three hypothesis tests to identify when Neyman's bias may be present in case–control studies. We apply these tests to three data sets, one of stroke mortality, another of brain tumors, and the last of atrial fibrillation, and find some evidence of Neyman's bias in the former two cases, but not the last case. 相似文献
49.
Jiantian Wang 《统计学通讯:理论与方法》2018,47(1):55-63
This paper studies the likelihood ratio ordering of parallel systems under multiple-outlier models. We introduce a partial order, the so-called θ-order, and show that the θ-order between the parameter vectors of the parallel systems implies the likelihood ratio order between the systems. 相似文献
50.
This paper presents some powerful omnibus tests for multivariate normality based on the likelihood ratio and the characterizations of the multivariate normal distribution. The power of the proposed tests is studied against various alternatives via Monte Carlo simulations. Simulation studies show our tests compare well with other powerful tests including multivariate versions of the Shapiro–Wilk test and the Anderson–Darling test. 相似文献